Accepted for Publication: September 17, 2013.
Published Online: December 9, 2013. doi:10.1001/jamainternmed.2013.12963.
Study concept and design: Tseng, Aron, Pogach.
Acquisition of data: Soroka, Maney, Pogach.
Analysis and interpretation of data: Tseng, Soroka, Aron, Pogach.
Drafting of the manuscript: Tseng, Soroka, Aron, Pogach.
Critical revision of the manuscript for important intellectual content: Tseng, Maney, Aron, Pogach.
Statistical analysis: Tseng, Soroka, Aron.
Obtained funding: Pogach.
Administrative, technical, and material support: Maney, Pogach.
Study supervision: Tseng, Pogach.
Conflict of Interest Disclosures: Dr Pogach is the co-chair of the Health and Human Services Adverse Drug Event Hypoglycemic Safety Federal Interagency Workgroup. Dr Aron was the Endocrine Society’s representative on the National Committee for Quality Assurance/American Medical Association Physicians Consortium on Performance Measures. No other disclosures were reported.
Funding/Support: This work was funded by a VA Health Services Research Development Diabetes Quality Enhancement Research Initiative, VA Clinical Epidemiological Research grant, and Health Services Research grant 08-355-2 (Dr Pogach).
Role of the Sponsor: The VA had no role in design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Disclaimer: The views expressed are solely those of the authors and do not necessarily reflect the views of the Department of Veterans Affairs or any other agency.
Previous Presentations: This study was presented in part at the American Diabetes Association 72nd Scientific Sessions; June 10, 2012; Philadelphia, Pennsylvania; and 73rd Scientific Sessions; June 23, 2013; Chicago, Illinois.